Ceballos-Picot I, Witko-Sarsat V, Merad-Boudia M, Nguyen A T, Thévenin M, Jaudon M C, Zingraff J, Verger C, Jungers P, Descamps-Latscha B
Department of Biochemistry, Necker Hospital, Paris, France.
Free Radic Biol Med. 1996;21(6):845-53. doi: 10.1016/0891-5849(96)00233-x.
A profound imbalance between oxidants and antioxidants has been suggested in uremic patients on maintenance hemodialysis. However, the respective influence of uremia and dialysis procedure has not been evaluated. Circulating levels of copper-zinc superoxide dismutase (CuZn SOD), glutathione peroxidase (GSH-Px), and reductase (GSSG-Rd), total GSH and GSSG were determined in a large cohort of 233 uremic patients including 185 undialyzed patients with mild to severe chronic renal failure, and 48 patients treated by peritoneal dialysis or hemodialysis. Compared to controls, erythrocyte GSH-Px and GSSG-Rd activities were significantly increased at the mild stage of chronic uremia (p < .001), whereas erythrocyte CuZn SOD activity was unchanged, total level of GSH and plasma GSH-Px activity were significantly decreased, and GSSG level and GSSG-Rd activity were unchanged. Positive Spearman rank correlations were observed between creatinine clearance and plasma levels of GSH-Px (r = .65, p < .001), selenium (r = .47, p < .001), and GSH (r = .41, p < .001). Alterations in antioxidant systems gradually increased with the degree of renal failure, further rose in patients on peritoneal dialysis and culminated in hemodialysis patients in whom an almost complete abolishment of GSH-Px activity was observed. In conclusion, such disturbances in antioxidant systems that occur from the early stage of chronic uremia and are exacerbated by dialysis provide additional evidence for a resulting oxidative stress that could contribute to the development of accelerated atherosclerosis and other long-term complications in uremic patients.
有研究表明,维持性血液透析的尿毒症患者体内氧化剂与抗氧化剂之间存在严重失衡。然而,尿毒症和透析过程各自的影响尚未得到评估。我们测定了233例尿毒症患者的循环铜锌超氧化物歧化酶(CuZn SOD)、谷胱甘肽过氧化物酶(GSH-Px)和还原酶(GSSG-Rd)水平、总GSH和GSSG水平,这组患者包括185例未透析的轻至重度慢性肾衰竭患者以及48例接受腹膜透析或血液透析的患者。与对照组相比,慢性尿毒症轻度阶段红细胞GSH-Px和GSSG-Rd活性显著升高(p <.001),而红细胞CuZn SOD活性未改变,GSH总水平和血浆GSH-Px活性显著降低,GSSG水平和GSSG-Rd活性未改变。肌酐清除率与血浆GSH-Px水平(r =.65,p <.001)、硒(r =.47,p <.001)和GSH(r =.41,p <.001)之间存在正Spearman等级相关性。抗氧化系统的改变随着肾衰竭程度的加重而逐渐增加,在腹膜透析患者中进一步升高,并在血液透析患者中达到顶峰,在这些患者中观察到GSH-Px活性几乎完全丧失。总之,这种从慢性尿毒症早期就出现并因透析而加剧的抗氧化系统紊乱,为由此产生的氧化应激提供了额外证据,这种氧化应激可能导致尿毒症患者加速动脉粥样硬化和其他长期并发症的发生。